This high AMPK activity decreased the migratory and invasive properties of the breast cancer cells, thus demonstrating the ability of the LKB1-AMPK pathway to inhibit breast cancer tumorigenesis [36]. This evidence concerns the gene STK11 and breast carcinoma.